Vimarsana
Biggest News Aggregation in the World

Page 43 - Device Designation News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Device Designation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Device Designation Today - Breaking & Trending Today

CytoSorbents Provides Preliminary Third Quarter Business Update and Revised 2021 Product Revenue Guidance - Vimarsana News

CytoSorbents Provides Preliminary Third Quarter Business Update and Revised 2021 Product Revenue Guidance

/PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in intensive care and cardiac surgery using...

Alpha Tau receives FDA nod for brain tumor device - Vimarsana News

Alpha Tau receives FDA nod for brain tumor device

Alpha DaRT has received FDA breakthrough designation for the treatment of patients with recurrent glioblastoma multiform (GBM).

Alpha Tau Receives FDA's Breakthrough Device Designation for the Treatment of Recurrent GBM - Vimarsana News

Alpha Tau Receives FDA's Breakthrough Device Designation for the Treatment of Recurrent GBM

/PRNewswire/ -- Alpha Tau Medical, the developer of the innovative alpha-radiation cancer therapy Alpha DaRT™, is pleased to announce that it has received...

FDA News | Latest News - NewsNow - Vimarsana News

FDA News | Latest News - NewsNow

Read the latest Food and Drug Administration headlines - updated 24/7/365. We link to the best sources from around the world. Get the latest on the FDA...

Amprion Announces SYNTap™ Biomarker Test For Early Detection Of Parkinson's Disease (PD), Lewy Body Dementia (LBD), And Alzheimer's Disease (AD) - Vimarsana News

Amprion Announces SYNTap™ Biomarker Test For Early Detection Of Parkinson's Disease (PD), Lewy Body Dementia (LBD), And Alzheimer's Disease (AD)

Amprion has announced the commercial rollout of its innovative SYNTap Biomarker Test, a first-in-class laboratory-developed test (LDT) for accurate...